today announced positive 12-month safety and biomarker results from the Phase 1b DONATELLO clinical trial evaluating GNSC-001, a potential first-in-class gene therapy blocking interleukin 1 (IL-1 ...

This suggests that their physiological responses to trauma dulled over time. Meanwhile, their interleukin 1B levels–those linked to inflammation–were higher. Interleukin 2R levels ...

J Gastroenterol Hepatol. 2008;23(10):1567-1573. In conclusion, the role of IL-1 and IL-2 polymorphisms in GU, GC, and DU is still controversial in Korea. Therefore, the ethnic and regional factors ...